| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 11 | |
| #2 | Australia | 7 | |
| #3 | Japan | 6 | |
| #4 | United States | 5 | |
| #5 | Hong Kong | 4 | |
| #6 | Canada | 3 | |
| #7 | Taiwan | 3 | |
| #8 | Argentina | 2 | |
| #9 | China | 2 | |
| #10 | Republic of Korea | 2 | |
| #11 | Malaysia | 2 | |
| #12 | Slovakia | 2 | |
| #13 | WIPO (World Intellectual Property Organization) | 2 | |
| #14 | Brazil | 1 | |
| #15 | Israel | 1 | |
| #16 | Mexico | 1 | |
| #17 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Seyfried Christoph | 13 |
| #2 | Gottschlich Rudolf | 13 |
| #3 | Mangel Allen | 12 |
| #4 | Bartoszyk Gerd | 11 |
| #5 | Weber Frank | 9 |
| #6 | Jacob Jutta | 9 |
| #7 | Barber Andrew | 8 |
| #8 | Ackermann Karl-August | 8 |
| #9 | Wiesner Matthias | 7 |
| #10 | Budak Jens | 7 |
| Publication | Filing date | Title |
|---|---|---|
| EP3558300A1 | Solid pharmaceutical formulations of asimadoline | |
| EP2136801A1 | Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome | |
| AU2007207867A1 | Kappa-opiate agonists for the treatment of bladder diseases | |
| CA2544245A1 | Use of selective opiate receptor modulators in the treatment of neuropathy |